| Detected | Trial | Change |
|---|---|---|
| 2026-08-09 | NCT04974866 Tyrosine Kinase Inhibitors in Metastastic Adenoid Cystic Carcinoma |
overall status: Recruiting → Unknown |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06500234 | Nutrition Impact on Immunotherapy of Cancer | Nutrition Disorders | Recruiting |
| NCT05175274 | Colchicine Use for Primary Prevention of Coronary Artery Disease | Coronary Artery Disease | Not Yet Recruiting |
| Phase 2/3 | |||
| NCT06138028 | Sintilimab and Chemotherapy Sequential Radiotherapy in Advanced Esophageal Cancer | Metastatic Esophageal Squamous Cell Carcinoma | Recruiting |
| Phase 2 | |||
| NCT07090525 | Bevacizumab Combined With Cisplatin Versus Cisplatin Monotherapy in Malignant Serous… | Overall Response Rate | Recruiting |
| NCT07322783 | Osimertinib Combined With Savolitinib in the Treatment of NSCLC With Low Copy Number MET… | EGFR Positive Non-small Cell Lung Cancer | Recruiting |
| NCT07090031 | Perioperative Treatment With TAS-102 in Combination With Oxaliplatin for Locally Advanced… | EFS | Active, Not Recruiting |
| Not specified | |||
| NCT06514118 | Chemoimmunotherapy Plus Residual Lesion Irradiation for the Treatment of Extensive Stage… | Small-cell Lung Cancer | Recruiting |